1. Clinical Overview
Anti Rh D Immunoglobulin (50mcg) is a sterile, concentrated solution of immunoglobulin G (IgG) containing antibodies against the Rh D antigen. It is derived from human plasma collected from screened donors. In the Indian context, it is a critical biological agent used for the prevention of Rh D alloimmunization (Rh sensitization) in Rh D-negative individuals exposed to Rh D-positive red blood cells. The 50mcg dose is typically used for specific indications like post-miscarriage or post-abortion prophylaxis.
| Onset | Duration | Bioavailability |
|---|---|---|
| Rapid, with detectable antibody levels within hours of intramuscular administration. | Approximately 4 to 6 weeks, providing a 'passive immunity' window sufficient to clear fetal Rh D-positive cells and prevent maternal sensitization. | Approximately 70-80% following intramuscular injection. Intravenous formulations have 100% bioavailability but are less common for this indication in India. |
2. Mechanism of Action
Anti Rh D Immunoglobulin contains high titers of antibodies specific to the Rh D antigen present on the surface of red blood cells (RBCs). When administered to an Rh D-negative individual, these antibodies bind to any circulating Rh D-positive fetal RBCs that have entered the maternal circulation. This opsonization marks the fetal cells for rapid destruction by macrophages in the spleen, thereby clearing them from the bloodstream before the mother's immune system can recognize the Rh D antigen and mount a primary, active immune response.
3. Indications & Uses
- Prevention of Rh D alloimmunization in Rh D-negative, non-sensitized women after delivery of an Rh D-positive baby.
- Prevention of Rh D alloimmunization in Rh D-negative women following spontaneous or induced abortion, miscarriage, or ectopic pregnancy after 12 weeks of gestation (or at any gestation if instrumentation is used).
4. Dosage & Administration
Adult Dosage: Standard postnatal dose: 300mcg (1500 IU) within 72 hours of delivery. The 50mcg (250 IU) dose is specifically indicated for events before 20 weeks gestation (e.g., miscarriage/abortion up to 12 weeks) or for very small fetomaternal hemorrhages (<2.5ml of fetal RBCs) as determined by a Kleihauer test.
Administration: For 50mcg dose: Administer by deep intramuscular injection, preferably into the deltoid muscle or anterolateral aspect of the thigh. Do not administer intravenously unless the product is specifically licensed for IV use. The injection should be given within 72 hours of the sensitizing event for optimal efficacy, though administration up to 9-10 days post-event may still offer some benefit.
5. Side Effects
Common side effects may include:
- Pain, tenderness, redness, or mild swelling at the injection site.
- Mild transient fever, malaise, or headache.
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Live Attenuated Vaccines (MMR, Varicella, Yellow Fever) | Anti-D Ig may interfere with the immune response to the live vaccine, potentially reducing its efficacy. | Major |
| Other Immunoglobulins | May increase the risk of systemic adverse reactions. | Moderate |
7. Patient Counselling
- DO inform all healthcare providers (including dentists) that you have received Anti-D Ig, as it can affect certain lab tests.
- DO keep a record of the date and dose administered in your medical/pregnancy records.
- DON'T receive any live virus vaccinations for at least 3 months after receiving Anti-D Ig without consulting your doctor.
- DO report any severe pain at the injection site, high fever, difficulty breathing, or rash to your doctor immediately.
8. Toxicology & Storage
Overdose: Overdose is unlikely with standard prophylactic dosing. Theoretical risks include exacerbation of common side effects (fever, chills, headache) and a higher likelihood of systemic hypersensitivity reactions.
Storage: Store at +2°C to +8°C in a refrigerator. Do not freeze. Protect from light. The vial should be kept in the outer carton. Do not use if the solution is cloudy or contains particulate matter. Once withdrawn into a syringe, administer promptly. Do not shake vigorously.